Murine chronic graft-versus-host disease proteome profiling discovers CCL15 as a novel biomarker in patients.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Blood

• Publication date

  2018-04-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/blood-2017-08-800623PMID 29348127PMCID PMC5897867
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association of Plasma CD163 Concentration with De Novo-Onset Chronic Graft-versus-Host Disease.

  2017cited by this paper
• B-cell activating factor (BAFF) plasma level at the time of chronic GvHD diagnosis is a potential predictor of non-relapse mortality

  2017cited by this paper
• The proteome pattern cGvHD_MS14 allows early and accurate prediction of chronic GvHD after allogeneic stem cell transplantation

  2017cited by this paper
• Pirfenidone ameliorates murine chronic GVHD through inhibition of macrophage infiltration and TGF-β production.

  2017cited by this paper
• Chronic graft-versus-host disease: biological insights from preclinical and clinical studies.

  2017cited by this paper
• The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease.

  2017cited by this paper
• Pathophysiology of Chronic Graft-versus-Host Disease and Therapeutic Targets.

  2017cited by this paper
• Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells.

  2016cited by this paper
• Upregulation of inflammatory gene transcripts in periosteum of chronic migraineurs: Implications for extracranial origin of headache

  2016cited by this paper
• Upregulation of IFN-Inducible and Damage-Response Pathways in Chronic Graft-versus-Host Disease

  2016cited by this paper
• Proteomic Characterization Reveals That MMP‐3 Correlates With Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Cell and Lung Transplantation

  2016cited by this paper
• Initiation of acute graft-versus-host disease by angiogenesis.

  2016cited by this paper
• Loss of SMAD4 Promotes Lung Metastasis of Colorectal Cancer by Accumulation of CCR1+ Tumor-Associated Neutrophils through CCL15-CCR1 Axis

  2016cited by this paper
• Proteomics analysis reveals a Th17-prone cell population in presymptomatic graft-versus-host disease.

  2016cited by this paper
• Biomarker Panel for Chronic Graft-Versus-Host Disease.

  2016cited by this paper
• Preclinical models of acute and chronic graft-versus-host disease: how predictive are they for a successful clinical translation?

  2016cited by this paper
• Role of neoplastic monocyte-derived fibrocytes in primary myelofibrosis

  2016cited by this paper
• National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease

  2015cited by this paper
• Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.

  2015cited by this paper
• Oncogenic Signaling Adaptor Proteins.

  2015cited by this paper
• CRK proteins selectively regulate T cell migration into inflamed tissues.

  2015cited by this paper
• National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report.

  2015cited by this paper
• Inflammatory Micro-Environmental Cues of Human Atherothrombotic Arteries Confer to Vascular Smooth Muscle Cells the Capacity to Trigger Lymphoid Neogenesis

  2014cited by this paper
• Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans.

  2014cited by this paper
• Biologic markers of chronic GVHD

  2014cited by this paper
• CSF-1-dependant donor-derived macrophages mediate chronic graft-versus-host disease.

  2014cited by this paper
• Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors

  2014cited by this paper
• The adaptor protein Crk in immune response

  2014cited by this paper
• Proteome Profiling of Cancer-Associated Fibroblasts Identifies Novel Proinflammatory Signatures and Prognostic Markers for Colorectal Cancer

  2013cited by this paper
• Endothelial cells recruit macrophages and contribute to a fibrotic milieu in bleomycin lung injury.

  2013cited by this paper
• ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death.

  2013cited by this paper
• Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis.

  2013cited by this paper
• CC-Chemokine CCL15 Expression and Possible Implications for the Pathogenesis of IgE-Related Severe Asthma

  2012cited by this paper
• Quantitative Salivary Proteomic Differences in Oral Chronic Graft-versus-Host Disease

  2012cited by this paper
• The chemokine superfamily revisited.

  2012cited by this paper
• Expression and regulation of CCL15 by human airway smooth muscle cells

  2012cited by this paper
• Models of crk adaptor proteins in cancer.

  2012cited by this paper
• Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans.

  2012cited by this paper
• Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium.

  2011cited by this paper
• Mouse CCL8, a CCR8 agonist, promotes atopic dermatitis by recruiting IL-5+ TH2 cells

  2011cited by this paper
• Discovery and validation of graft-versus-host disease biomarkers.

  2011cited by this paper
• Decrease of CD4(+)CD25(+) regulatory T cells and TGF-beta at early immune reconstitution is associated to the onset and severity of graft-versus-host disease following allogeneic haematogenesis stem cell transplantation.

  2010cited by this paper
• The evolution of mammalian chemokine genes.

  2010cited by this paper
• Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation.

  2010cited by this paper
• Inactivation of chemokine (C-C motif) receptor 1 (CCR1) suppresses colon cancer liver metastasis by blocking accumulation of immature myeloid cells in a mouse model

  2010cited by this paper
• Reduced mortality after allogeneic hematopoietic-cell transplantation.

  2010cited by this paper
• An unrecognized extracellular function for an intracellular adapter protein released from the cytoplasm into the tumor microenvironment

  2009cited by this paper
• Protein levels of CC chemokine ligand (CCL)15, CCL16 and macrophage stimulating protein in patients with sarcoidosis

  2009cited by this paper
• CCL8 is a potential molecular candidate for the diagnosis of graft-versus-host disease.

  2008cited by this paper
• Crk and Crk-Like Play Essential Overlapping Roles Downstream of Disabled-1 in the Reelin Pathway

  2008cited by this paper
• Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study.

  2007cited by this paper
• SMAD4-deficient intestinal tumors recruit CCR1+ myeloid cells that promote invasion

  2007cited by this paper
• High Levels of B-Cell Activating Factor in Patients with Active Chronic Graft-Versus-Host Disease

  2007cited by this paper
• CCR1/CCL5 (RANTES) receptor-ligand interactions modulate allogeneic T-cell responses and graft-versus-host disease following stem-cell transplantation.

  2007cited by this paper
• Expression of CCL9/MIP-1γ is repressed by BCR/ABL and its restoration suppresses in vivo leukemogenesis of 32D-BCR/ABL cells

  2007cited by this paper
• Invasive and noninvasive methods for studying pulmonary function in mice

  2007cited by this paper
• Donor CD4+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations.

  2006cited by this paper
• Donor T-cell production of RANTES significantly contributes to the development of idiopathic pneumonia syndrome after allogeneic stem cell transplantation.

  2005cited by this paper
• National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.

  2005cited by this paper
• Proteolytic Activation of Alternative CCR1 Ligands in Inflammation1

  2005cited by this paper
• Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study.

  2005cited by this paper
• National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

  2005cited by this paper
• Association of Foxp3 regulatory gene expression with graft-versus-host disease.

  2004cited by this paper
• Uric Acid Stimulates Monocyte Chemoattractant Protein‐1 Production in Vascular Smooth Muscle Cells Via Mitogen‐Activated Protein Kinase and Cyclooxygenase‐2

  2003cited by this paper
• CCL9 Is Secreted by the Follicle-Associated Epithelium and Recruits Dome Region Peyer’s Patch CD11b+ Dendritic Cells 1

  2003cited by this paper
• Platelet-Derived Chemokines CXC Chemokine Ligand (CXCL)7, Connective Tissue-Activating Peptide III, and CXCL4 Differentially Affect and Cross-Regulate Neutrophil Adhesion and Transendothelial Migration1

  2002cited by this paper
• Crk family adaptors–signalling complex formation and biological roles

  2001cited by this paper
• Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.

  1999cited by this paper
• Long-Term Survival and Late Deaths after Allogeneic Bone Marrow Transplantation

  1999cited by this paper
• Characterisation of macrophage inflammatory protein-5/human CC cytokine-2, a member of the macrophage-inflammatory-protein family of chemokines.

  1997cited by this paper
• Dendritic cells produce macrophage inflammatory protein-1 gamma, a new member of the CC chemokine family.

  1996cited by this paper
• Molecular cloning and functional characterization of a novel member of the C-C chemokine family.

  1995cited by this paper

• Macrophages in graft-versus-host disease (GVHD): dual roles as therapeutic tools and targets

  2025cites this paper
• Current status, challenges, and integration pathways of biomarker classification systems in graft-versus-host disease: a preliminary exploration

  2025cites this paper
• Immune Monitoring after Cell Therapy and Hematopoietic Cell Transplantation: Guidelines by the ISCT Stem Cell Engineering Committee

  2025cites this paper
• Biomarkers in the early stage of PD-1 inhibitor treatment have shown superior predictive capabilities for immune-related thyroid dysfunction

  2024cites this paper
• Efficiency and Toxicity of Imatinib Mesylate Combined with Atorvastatin Calcium in the Treatment of Steroid-Refractory Chronic Graft-versus-Host Disease: A Single-Center, Prospective, Single-Arm, Open-Label Study

  2024cites this paper
• Identification of Hub Genes Correlated with the Initiation and Development in Chronic Kidney Disease via Bioinformatics Analysis

  2023cites this paper
• CD146+ Umbilical Cord Mesenchymal Stem Cells Exhibit High Immunomodulatory Activity and Therapeutic Efficacy in Septic Mice

  2023cites this paper
• Management of Chronic Graft-vs.-Host Disease in Children and Adolescents With ALL: Present Status and Model for a Personalised Management Plan

  2022cites this paper
• Multifaceted Roles of Chemokine C-X-C Motif Ligand 7 in Inflammatory Diseases and Cancer

  2022cites this paper
• Asthma and Post-Asthmatic Fibrosis: A Search for New Promising Molecular Markers of Transition from Acute Inflammation to Pulmonary Fibrosis

  2022cites this paper
• CCL8 deficiency in the host abrogates early mortality of acute graft-versus-host disease in mice with dysregulated IL-6 expression.

  2021cites this paper
• Macrophage regulation of graft-vs-host disease

  2020cites this paper
• Post‐haematopoietic cell transplantation outcomes: why ST2 became a ‘golden nugget’ biomarker

  2020cites this paper
• Biomarkers for Allogeneic HCT Outcomes

  2020cites this paper
• Dickkopf-related protein 3 is a novel biomarker for chronic GVHD after allogeneic hematopoietic cell transplantation.

  2020cites this paper
• Identifying the molecular and cellular signature of cardiac dilation following myocardial infarction.

  2019cites this paper
• 慢性移植物抗宿主病患者血清特异性生物标志物的临床研究

  2019cites this paper
• The use of ibrutinib before and after allogeneic stem cell transplantation

  2019cites this paper
• Chemokines: a novel chronic GVHD target.

  2018cites this paper
• The search for drug-targetable diagnostic, prognostic and predictive biomarkers in chronic graft-versus-host disease

  2018cites this paper
• Biomarkers for posttransplantation outcomes.

  2018cites this paper
• How ibrutinib, a B-cell malignancy drug, became an FDA-approved second-line therapy for steroid-resistant chronic GVHD.

  2018cites this paper
• The use of Bruton's tyrosine kinase inhibition as a bridging strategy to successful allogeneic stem cell transplant in relapsed mantle cell lymphoma

  2016cites this paper
• Chemokines and Graft-Versus-Host Disease

  2013cites this paper